Multimorbidity and adverse outcomes following emergency department attendance: population based cohort study [0.03%]
多病共存对急诊科就诊后不良后果的影响：基于人口的队列研究
Michael C Blayney,Matthew J Reed,John A Masterson et al.
Michael C Blayney et al.
Objectives: To describe the effect of multimorbidity on adverse patient centred outcomes in people attending emergency department. Design: ...
Development and validation of a prognostic model to predict birth weight: individual participant data meta-analysis [0.03%]
用于预测出生体重的预后模型的开发和验证：个体患者数据的荟萃分析
John Allotey,Lucinda Archer,Kym I E Snell et al.
John Allotey et al.
Objective: To predict birth weight at various potential gestational ages of delivery based on data routinely available at the first antenatal visit. Desig...
Youri Yordanov,Agathe Beauvais,Pierre-Clément Thiébaud
Youri Yordanov
Fostering diversity in clinical trials: need for evidence and implementation to improve representation [0.03%]
临床试验中培育多样性：需要证据和实施以提高代表性
David Collister,Claire Song,Shannon M Ruzycki
David Collister
Age and sex specific thresholds for risk stratification of cardiovascular disease and clinical decision making: prospective open cohort study [0.03%]
基于年龄和性别的心血管疾病风险分层和临床决策的阈值：前瞻性开放队列研究
Zhe Xu,Juliet Usher-Smith,Lisa Pennells et al.
Zhe Xu et al.
Objective: To quantify the potential advantages of using 10 year risk prediction models for cardiovascular disease, in combination with risk thresholds specific to both age and sex, to identify individuals at high risk of...
Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies [0.03%]
利用政策促进包容性医疗产品证据的制定：参考标准和临床试验多样性政策的结构化审计的发展
Jennifer Miller,William Pelletiers,Sakinah Suttiratana et al.
Jennifer Miller et al.
Objective: To develop a reference standard based on US Food and Drug Administration and stakeholder guidance for pharmaceutical companies' policies on diversity in clinical trials and to assess these policies. ...
Progressive pulmonary fibrosis: a need for real world data to solve real world clinical problems [0.03%]
进行性肺纤维化：需要真实世界的数据来解决实际的临床问题
Huajian Liu,Kerri-Marie Heenan,Liam Coyle et al.
Huajian Liu et al.
All cause and cause specific mortality in 15-24-year-olds in Denmark 2010 to 2022: nationwide study of socioeconomic predictors [0.03%]
丹麦2010年至2022年15至24岁人群全因和特因死亡率的全国性研究：社会经济预测因素的影响
Sofie Kruckow,Janne S Tolstrup
Sofie Kruckow
Objective: To assess inequalities in all cause and cause specific mortality in young people and if there are differences across gender and age groups. Des...
Emily Prior,Sabita Uthaya
Emily Prior
Assessing the methodological quality and risk of bias of systematic reviews: primer for authors of overviews of systematic reviews [0.03%]
系统评价的方法学质量和偏倚风险评估：综述性系统评价作者入门指南
Carole Lunny,Salmaan Kanji,Pierre Thabet et al.
Carole Lunny et al.